{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:00:02Z","timestamp":1790964002540,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.2353\/ajpath.2009.080055","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T13:56:19Z","timestamp":1240581379000},"page":"1869-1879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL\/6 Mice via mTOR-Dependent Growth"],"prefix":"10.1016","volume":"174","author":[{"given":"Jorge","family":"Blando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Portis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvanesh","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio J.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Lyn","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2009.080055_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene. MMAC1, at chromosome 10q233 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080055_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2009.080055_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0962-8924(03)00175-2","article-title":"PTEN: from pathology to biology","volume":"13","author":"Sulis","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.2353\/ajpath.2009.080055_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Hum Mutat"},{"key":"10.2353\/ajpath.2009.080055_bib5","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2009.080055_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2009.080055_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras. PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.2353\/ajpath.2009.080055_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2009.080055_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080055_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tibs.2003.09.003","article-title":"Rheb fills a GAP between TSC and TOR","volume":"28","author":"Manning","year":"2003","journal-title":"Trends Biochem Sci"},{"key":"10.2353\/ajpath.2009.080055_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibs.2003.11.007","article-title":"TSC2: filling the GAP in the mTOR signaling pathway","volume":"29","author":"Li","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.2353\/ajpath.2009.080055_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1083\/jcb.200507119","article-title":"Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning","volume":"173","author":"Cai","year":"2006","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2009.080055_bib13","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1073\/pnas.95.9.5246","article-title":"Inactivation of the tumor suppressor PTEN\/MMAC1 in advanced human prostate cancer through loss of expression","volume":"95","author":"Whang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib14","first-page":"4800","article-title":"Loss of the chromosomal region 10q23\u201325 in prostate cancer","volume":"55","author":"Gray","year":"1995","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib15","first-page":"4997","article-title":"Frequent inactivation of PTEN\/MMAC1 in primary prostate cancer","volume":"57","author":"Cairns","year":"1997","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib16","first-page":"204","article-title":"Interfocal heterogeneity of PTEN\/MMAC1 gene alterations in multiple metastatic prostate cancer tissues","volume":"58","author":"Suzuki","year":"1998","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib17","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)80674-1","article-title":"The multiple roles of PTEN in tumor suppression","volume":"100","author":"Di Cristofano","year":"2000","journal-title":"Cell"},{"key":"10.2353\/ajpath.2009.080055_bib19","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1101\/gad.819500","article-title":"Molecular genetics of prostate cancer","volume":"14","author":"Abate-Shen","year":"2000","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2009.080055_bib20","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1073\/pnas.96.4.1563","article-title":"Mutation of Pten\/Mmac1 in mice causes neoplasia in multiple organ systems","volume":"96","author":"Podsypanina","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is essential for embryonic development and tumour suppression","volume":"19","author":"Di Cristofano","year":"1998","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080055_bib22","first-page":"3605","article-title":"High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+\/\u2212 mice","volume":"60","author":"Stambolic","year":"2000","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib23","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1158\/0008-5472.CAN-05-4143","article-title":"Genetic background controls tumor development in PTEN-deficient mice","volume":"66","author":"Freeman","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.0308217100","article-title":"Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten","volume":"101","author":"Backman","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib25","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1371\/journal.pbio.0000059","article-title":"Pten dose dictates cancer progression in the prostate","volume":"1","author":"Trotman","year":"2003","journal-title":"PLoS Biol"},{"key":"10.2353\/ajpath.2009.080055_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","article-title":"Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.2353\/ajpath.2009.080055_bib27","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1158\/0008-5472.CAN-04-4519","article-title":"Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis","volume":"65","author":"Ma","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib28","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1073\/pnas.0712021105","article-title":"Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma","volume":"105","author":"Ratnacaram","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/84879","article-title":"Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse","volume":"27","author":"Di Cristofano","year":"2001","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2009.080055_bib30","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.042688999","article-title":"Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis","volume":"99","author":"Kim","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib31","first-page":"3886","article-title":"Nkx3.1;Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases","volume":"63","author":"Abate-Shen","year":"2003","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib32","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.201167798","article-title":"Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression","volume":"98","author":"Kwabi-Addo","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2009.080055_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.2353\/ajpath.2009.080055_bib34","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.1699608","article-title":"Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events","volume":"22","author":"Nardella","year":"2008","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2009.080055_bib35","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1158\/0008-5472.CAN-07-5169","article-title":"Lkb1 deficiency causes prostate neoplasia in the mouse","volume":"68","author":"Pearson","year":"2008","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib36","series-title":"Tuberous Sclerosis Complex","first-page":"3","author":"Gomez","year":"1999"},{"key":"10.2353\/ajpath.2009.080055_bib37","first-page":"1206","article-title":"Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2009.080055_bib39","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.1314405","article-title":"Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression","volume":"19","author":"Ma","year":"2005","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2009.080055_bib40","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Manning","year":"2005","journal-title":"Genes Dev"},{"key":"10.2353\/ajpath.2009.080055_bib41","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/0008-5472.CAN-03-0946","article-title":"Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee","volume":"64","author":"Shappell","year":"2004","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jcp.53.12.929","article-title":"Audit and internal quality control in immunohistochemistry","volume":"53","author":"Maxwell","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.2353\/ajpath.2009.080055_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/jcp.52.1.75","article-title":"Comparison of different scoring systems for immunohistochemical staining","volume":"52","author":"Adams","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.2353\/ajpath.2009.080055_bib44","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1158\/0008-5472.CAN-05-3440","article-title":"Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis","volume":"66","author":"Zhong","year":"2006","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib45","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1158\/0008-5472.CAN-04-3137","article-title":"Effects of the mammalian target of rapamycin inhibitor CCI-779 used alone or with chemotherapy on human prostate cancer cells and xenografts","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib46","first-page":"6141","article-title":"Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells","volume":"62","author":"Grunwald","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm1052","article-title":"mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways","volume":"10","author":"Majumder","year":"2004","journal-title":"Nat Med"},{"key":"10.2353\/ajpath.2009.080055_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1677\/erc.0.0110225","article-title":"Genetically defined mouse models that mimic natural aspects of human prostate cancer development","volume":"11","author":"Roy-Burman","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.2353\/ajpath.2009.080055_bib49","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0002-9440(10)64853-5","article-title":"Development of spontaneous mammary tumors in BALB\/c p53 heterozygous mice. A model for Li-Fraumeni syndrome","volume":"157","author":"Kuperwasser","year":"2000","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2009.080055_bib50","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/gb-2007-8-6-r117","article-title":"Genetic background influences murine prostate gene expression: implications for cancer phenotypes","volume":"8","author":"Bianchi-Frias","year":"2007","journal-title":"Genome Biol"},{"key":"10.2353\/ajpath.2009.080055_bib51","first-page":"2999","article-title":"Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2009.080055_bib52","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1073\/pnas.0708476104","article-title":"Identification of prostate cancer modifier pathways using parental strain expression mapping","volume":"104","author":"Xu","year":"2007","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010610449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010610449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:06:47Z","timestamp":1757599607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010610449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0002944010610449"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2009.080055","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTEN Deficiency Is Fully Penetrant for Prostate Adenocarcinoma in C57BL\/6 Mice via mTOR-Dependent Growth","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2009.080055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}